CompletedNCT03894085
Definitive Selection of Neuroimaging Biomarkers in Anxiety Disorder and OCD: A Longitudinal Functional Magnetic Resonance Imaging （fMRI） Study With Paroxetine Treatment
Medication studyAges 18–56China
Understand this study
Who was this study for?
Listed age limits: 18 years to 56 years.
- Listed locations
- ChangshaSee all locations and recruitment
Study information
Study start dateStarted: May 30, 2019
- Recruitment status
- Completed
- Enrollment listed in the registry
- 150
- Sponsor
- Central South University
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Not clearly listed
- Locations
- China
- Age range
- From 18 Years to 56 Years
- Official registry ID
- NCT03894085
- Official title
Show the full official title
Definitive Selection of Neuroimaging Biomarkers in Anxiety Disorder and Obsessive-compulsive Disorder: A Longitudinal Functional Magnetic Resonance Imaging （ fMRI ）Study With Paroxetine Treatment
Get this study by email
Recruitment & locations
CompletedChangsha
Questions about this study
Who is behind this study?
The study sponsor is Central South University, a university.
Did this study involve medication?
Yes. The study involved medication, including Paroxetine.
Who was this study for?
Listed age limits: 18 years to 56 years.
